AAAAAA

   
Results: 1-13 |
Results: 13
Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes
Authors: Densmore, CL Kleinerman, ES Gautam, A Jia, SF Xu, B Worth, LL Waldrep, JC Fung, YK T'Ang, A Knight, V
Citation: Cl. Densmore et al., Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes, CANC GENE T, 8(9), 2001, pp. 619-627
Biologic response modifiers in pediatric cancer
Authors: Worth, LL Jeha, SS Kleinerman, ES
Citation: Ll. Worth et al., Biologic response modifiers in pediatric cancer, HEMAT ONCOL, 15(4), 2001, pp. 723
E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs
Authors: Zhou, ZC Jia, SF Hung, MC Kleinerman, ES
Citation: Zc. Zhou et al., E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs, CANCER RES, 61(8), 2001, pp. 3394-3398
Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells
Authors: Lafleur, EA Jia, SF Worth, LL Zhou, ZC Owen-Schaub, LB Kleinerman, ES
Citation: Ea. Lafleur et al., Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells, CANCER RES, 61(10), 2001, pp. 4066-4071
Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase II alpha gene transfer is independent of topoisomerase II beta
Authors: Zhou, Z Zwelling, LA Ganapathi, R Kleinerman, ES
Citation: Z. Zhou et al., Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase II alpha gene transfer is independent of topoisomerase II beta, BR J CANC, 85(5), 2001, pp. 747-751
Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases
Authors: Worth, LL Jia, SF Zhou, ZC Chen, L Kleinerman, ES
Citation: Ll. Worth et al., Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases, CLIN CANC R, 6(9), 2000, pp. 3713-3718
9-nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice
Authors: Koshkina, NV Kleinerman, ES Waldrep, C Jia, SF Worth, LL Gilbert, BE Knight, V
Citation: Nv. Koshkina et al., 9-nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice, CLIN CANC R, 6(7), 2000, pp. 2876-2880
Interferon-alpha enhances the sensitivity of human osteosarcoma cells to etoposide
Authors: Jia, SF An, TH Worth, L Kleinerman, ES
Citation: Sf. Jia et al., Interferon-alpha enhances the sensitivity of human osteosarcoma cells to etoposide, J INTERF CY, 19(6), 1999, pp. 617-624
ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity
Authors: Worth, LL Jia, SF An, T Kleinerman, ES
Citation: Ll. Worth et al., ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity, CANCER IMMU, 48(6), 1999, pp. 312-320
A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies
Authors: Jia, SF Worth, LL Kleinerman, ES
Citation: Sf. Jia et al., A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies, CLIN EXP M, 17(6), 1999, pp. 501-506
Adenovirus-mediated human Topoisomerase II alpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells
Authors: Zhou, ZC Zwelling, LA Kawakami, Y An, TH Kobayashi, K Herzog, C Kleinerman, ES
Citation: Zc. Zhou et al., Adenovirus-mediated human Topoisomerase II alpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells, CANCER RES, 59(18), 1999, pp. 4618-4624
Liposomal muramyl tripeptide (CGP 19835A lipid) therapy for resectable melanoma in patients who were at high risk for relapse: An update
Authors: Gianan, MAV Kleinerman, ES
Citation: Mav. Gianan et Es. Kleinerman, Liposomal muramyl tripeptide (CGP 19835A lipid) therapy for resectable melanoma in patients who were at high risk for relapse: An update, CANC BIO R, 13(5), 1998, pp. 363-368
Systemic activation of macrophages by liposomes containing synthetic immunomodulators for treatment of metastatic disease
Authors: Worth, LL Fidler, IJ Kleinerman, ES
Citation: Ll. Worth et al., Systemic activation of macrophages by liposomes containing synthetic immunomodulators for treatment of metastatic disease, MEDICAL APPLICATIONS OF LIPOSOMES, 1998, pp. 47-60
Risultati: 1-13 |